Neurosurgery Customer from Germany Orders Nexstim NBS System 5
Press release, Helsinki, 26 April 2024 at 3 PM (EEST) Neurosurgery Customer from Germany Orders Nexstim NBS System 5 Nexstim...
Brain
Nexstim Plc Business Update Q1 2024
Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim”...
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also...
NUTRACEUTICAL INNOVATOR STEMREGEN® BOLSTERS LEADERSHIP TEAM WITH INDUSTRY INSIDERS FOCUSED ON EXPANSION GOALS
AUSTIN, Texas, April 25, 2024 /PRNewswire/ -- STEMREGEN®, the pioneer in stem cell science creating the most powerful supplements that...
Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression
SAN FRANCISCO, April 25, 2024 /PRNewswire/ -- Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on...
FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way...
AlzeCure Publishes its Interim Report for January – March 2024
STOCKHOLM, SWEDEN / ACCESSWIRE / April 25, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
Psirenity Health and Pickleball Ontario Sign a Three-Year Partnership
Psirenity Health will be the Official "Wellness Partner" of Pickleball OntarioOakville, Ontario--(Newsfile Corp. - April 24, 2024) - Psirenity Health...
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Laxxon Medical, a leading 3D screen printing platform technology company,...
Exploring Brain Synchronization Patterns During Social Interactions
Researchers investigate how social bonds influence neural synchronization in the brain during joint coordination tasks Social interactions synchronize brain activity...
Anne Arundel Dermatology Adds Intelligent Scheduling Capabilities to Improve Patient Experience
Relatient’s centralized scheduling platform and patient self-scheduling tools will enhance patient access while streamlining staff workflowsATLANTA--(BUSINESS WIRE)--#DashEngage--Anne Arundel Dermatology (AADerm),...
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
Data on the company’s portable MR imaging system show it can acquire brain images at the point of care that...
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release first...
CNS Pharmaceuticals to Present at the LSX World Congress 2024
Presentation on Monday, April 29th at 4:15 PM (GMT+1)HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc....
Nava Health Expands Columbia Location to Meet Growing Demand for Integrative and Functional Medicine
Nava Health in Columbia Increases Space as Local Demand Shows No Signs of Slowing COLUMBIA, MD / ACCESSWIRE / April...
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Provides Further Evidence of Multiple Opportunities for Development of the FABP Inhibitor Platform in Cancer & Other Serious ConditionsSOLANA BEACH,...
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
Live video webcast with Chief Executive Officer, John Climaco, on Tuesday, April 23rd at 12:00 PM ETHOUSTON, TX / ACCESSWIRE...
FSD Pharma Provides Another Update on Celly Nu’s Anticipated Launch of unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way...
Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters
Selective CVN293 may have treatment potential in multiple neurodegenerative conditionsBOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused...
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
Plus now has $23 million in active awards support for the Company’s targeted radiotherapeutic pipeline Funding for pediatric brain cancer...